The numbers

MRC Technology protects and translates scientific discoveries from the UK Medical Research Council-funded Units and Institutes. The MRC’s budget for this in 2008/2009 was £355 million.

At the start of 2009, total licensing income generated by MRC Technology stood at over £434 million.

The Centre for Therapeutic Discovery has capacity for 8 small molecue and 5 antibody projects per year. This is set to increase to 16 small molecule and 8 antibody projects per year over the next 18 months.

Up to July 2009, DGF has invested over GBP£7 million in 67 early stage research projects with commercial potential.

Over 20 companies are licensed to sell our research reagents.